medicine

Showing 15 posts of 41 posts found.

francesa

US Congressmen accuse Teva of price hikes over 1,000%

August 21, 2017
Sales and Marketing Copaxone, Teva, life sciences, medicine, multiple sclerosis, pharma, pharmaceutical, price hiking

A pair of US Congressmen have fired allegations at Israeli drugmaker Teva accusing the firm of hiking the price of …

shutterstock_87495637

New study debunks hypothesis that antidepressants are ineffective

August 21, 2017
Research and Development, Sales and Marketing SSRIs, anti-depressants, citalopram, life sciences, medicine, paroextine, pharma, pharmaceuticals

A research group at the Sahlgrenska Academy at the University of Gothenburg in Sweden have released findings rebutting the claim …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 18, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten

A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …

novo_flag

Novo diabetes drug outperforms Lilly rival at Phase 3

August 17, 2017
Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …

shutterstock

New personalised molecular blood test could shake up cancer treatment

August 16, 2017
Research and Development Cancer, life sciences, medicine, pharma, pharmaceutical, standford university

A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …

NICE knocks back advanced kidney cancer drug duo

August 14, 2017
Sales and Marketing Cancer, Kidney cancer, NICE, medicine, pharma, pharmaceutical

NICE has dished out a double judgement turning down two drugs for advanced renal cell carcinoma, a form of kidney …

Takeda strikes partnership to develop single-drug cancer combo immunotherapies

August 14, 2017
Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, immunotherapy, medicine, pharma, pharmaceuticals

Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …

shutterstock_95714119

Over 1,000 currently active cancer trials spell trouble for patient recruitment

August 14, 2017
Medical Communications, Research and Development, Sales and Marketing Cancer, drugs, life sciences, medicine, pharma, pharmaceutical

The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …

FDA investigating intragastric obesity treatment linked to five deaths

August 14, 2017
Medical Communications, Sales and Marketing life sciences, medicine, obesity, pharma, pharmaceutical

The FDA has launched an investigation after five deaths thought to be caused by an obesity treatment surgery in which …

celgene_1_02

Celgene opts not to acquire Sutro Biopharma for $1bn, reworks existing partnership

August 11, 2017
Medical Communications, Sales and Marketing Celgene, Sutro Biopharma, biotech, healthcare, life sciences, medicine, pharma, pharmaceutical

Celgene has announced that it has chosen not to scoop up Sutro Biopharma, rejecting to take advantage of an option …

brain-1787622_640

Early-stage study gives hope for rare and fatal neurodegenerative condition

August 11, 2017
Medical Communications, Research and Development biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …

shutterstock_87495637

Ending the era of $100,000 cancer drugs

August 11, 2017
Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …

The Gateway to Local Adoption Series

Latest content